Coherus Oncology Inc (CHRS)

Income Before Tax

-$161.15M

TTM · Period ending: · USD

CHRS logo

CHRS Income Before Tax

Latest reported-$161.15M
CHRS TTM Pre-Tax Income (-$53.64M → -$161.15M)
High-resolution chart · PNG

CHRS income before tax history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Coherus Oncology Inc Income Before Tax — Trailing twelve months (TTM) (USD)
Period endingIncome Before Tax (USD)
-161,146,000
-172,661,000
-183,124,000
-187,473,000
-153,707,000
-121,766,000
-142,404,000
-171,361,000
-200,631,000
-230,579,000
-238,272,000
-217,489,000
-264,118,000
-271,399,000
-291,754,000
-278,609,000
-230,487,000
-210,237,000
-287,100,000
-230,615,000
-163,971,000
-73,746,000
135,706,000
166,217,000
185,991,000
149,284,000
92,775,000
-11,092,000
-117,808,000
-185,111,000
-209,409,000
-195,882,000
-196,049,000
-207,766,000
-238,286,000
-265,161,000
-122,324,000
-137,072,000
-127,788,000
-104,424,000
-259,753,000
-248,637,000
-223,938,000
-200,381,000
-136,810,000
-102,846,000
-87,177,000
-72,745,000
-86,304,000
-69,943,000
-53,635,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.